Related Experiment Videos
Gene therapy for vein graft disease
1Division of Cardiovascular Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. cable.david@mayo.edu
Current Cardiology Reports
|January 5, 2001
Summary
Gene therapy for vein graft disease needs understanding of its causes. This review covers vein graft disease, gene transfer to veins, and genes impacting vascular biology.
Area of Science:
- Vascular Biology
- Gene Therapy
- Regenerative Medicine
Background:
- Vein graft disease is a significant complication following vascular surgery.
- Understanding the pathophysiology of vein graft disease is crucial for developing effective treatments.
- Gene therapy offers a promising avenue for managing vein graft disease.
Purpose of the Study:
- To provide a comprehensive overview of vein graft disease.
- To review existing data on gene transfer techniques applicable to veins.
- To identify key genes that influence vascular biology in the context of vein grafts.
Main Methods:
- Literature review of published and unpublished studies on vein graft disease.
- Analysis of gene transfer methods and their efficacy in venous tissues.
- Identification and categorization of genes with significant impact on vascular remodeling.
Main Results:
- Vein graft disease involves complex cellular and molecular processes.
- Various gene transfer strategies have shown potential in preclinical models.
- Specific genes have been identified as critical targets for therapeutic intervention.
Conclusions:
- Effective gene therapeutics for vein graft disease require a deep understanding of its pathophysiology.
- Further research into gene transfer and target gene identification is warranted.
- Gene therapy holds promise for improving outcomes in patients undergoing vein grafting procedures.